Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 3:04 PM ET | Feedback | Site Changes | Help
The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.
View All Commentary (GSK)
Recs
GlobalGains (< 20) Submitted: 7/24/08 11:35 AM : Start Price: $46.23 GSK Score: 6.10
GSK stock is under valued by > $10.00 p/share. Progressive development pipeline along with new CEO will grow this Global player to new heights within the next two years. They maintain excellent balance between Rx and OTC products and I expect to see wide growth in the OTC consumer products division. I can see this stock reaching $54.00+ within next 12 months and should be $60.00 within 24.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK